(Q35788831)

10 August 2017

title

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients (English)

1 reference

10 August 2017

3

Yukihiko Sonoda

1 reference

10 August 2017

8

Tatsuhiro Shibata

1 reference

10 August 2017

Masayuki Kanamori

1

1 reference

10 August 2017

Tsuyoshi Higa

2

1 reference

10 August 2017

Shohei Murakami

4

1 reference

10 August 2017

Mina Dodo

5

1 reference

10 August 2017

Hiroshi Kitamura

6

1 reference

10 August 2017

Keiko Taguchi

7

1 reference

10 August 2017

Mika Watanabe

9

1 reference

10 August 2017

Hiroyoshi Suzuki

10

1 reference

10 August 2017

Ichiyo Shibahara

11

1 reference

10 August 2017

Ryuta Saito

12

1 reference

10 August 2017

Yoji Yamashita

13

1 reference

10 August 2017

Toshihiro Kumabe

14

1 reference

10 August 2017

Masayuki Yamamoto

15

1 reference

10 August 2017

Hozumi Motohashi

16

1 reference

10 August 2017

Teiji Tominaga

17

1 reference

10 August 2017

publication date

10 October 2014

1 reference

10 August 2017

1 reference

10 August 2017

volume

17

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

555-565

1 reference

describes a project that uses

10 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4483074/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Analysis of the IDH1 codon 132 mutation in brain tumors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

An integrated genomic analysis of human glioblastoma multiforme

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Nrf2-Keap1 defines a physiologically important stress response mechanism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

12 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Somatic mutations of the KEAP1 gene in common solid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25304134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25304134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NEUONC/NOU282

1 reference

10 August 2017

1 reference

10 August 2017

1 reference